Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
Sponsored by Johns Hopkins University
About this study
This research is being done to better understand rejection in transplant recipients with HIV who receive kidneys from donors with vs without HIV.
Previously, people with HIV in need of a transplant could only receive organs from a donor without HIV. However, in November 2013, the HIV Organ Policy Equity (HOPE) Act made it possible for people with HIV to receive organs from donors with HIV as a part of a research study. Over the last two decades, people with HIV have received organs from donors without HIV, and in general, these recipients have done well after transplant and still maintained control of their HIV. Over the last several years, people with HIV have received organs from donors with HIV, and in general, these recipients have also done well after transplant and still maintained control of their HIV. This study will look to better understand rejection in transplant recipients with HIV (HIVR+) who receive kidneys from donor…
Where this study is enrolling (17)
- I'm interested
University of Alabama at Birmingham
Birmingham, Alabama
- I'm interested
University of California, San Diego
San Diego, California
- I'm interested
University of California, San Francisco
San Francisco, California
- I'm interested
University of California, Davis
Sacramento, California
- I'm interested
Mayo Clinic Florida
Jacksonville, Florida
Show all 17 locations
- I'm interested
Northwestern University
Chicago, Illinois
- I'm interested
Rush University Medical Center
Chicago, Illinois
- I'm interested
Ochsner Clinic Foundation
New Orleans, Louisiana
- I'm interested
Johns Hopkins University
Baltimore, Maryland
- I'm interested
Massachusetts General Hospital
Boston, Massachusetts
- I'm interested
Washington University St. Louis Barnes Jewish Hospital
St Louis, Missouri
- I'm interested
Weill Cornell Medical Center
New York, New York
- I'm interested
Icahn School of Medicine at Mt. Sinai
New York, New York
- I'm interested
New York University
New York, New York
- I'm interested
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
- I'm interested
University of Pennsylvania
Philadelphia, Pennsylvania
- I'm interested
Houston Methodist Research Institute
Houston, Texas
Who can participate
Inclusion criteria
- ✓Participant meets local criteria for kidney transplant.
- ✓Participant is able to understand and provide informed consent.
- ✓Participant has documented HIV infection by any licensed assay or documented history of detectable HIV-1 RNA.
- ✓Participant is ≥ 18 years old.
- ✓HIV-1 RNA \< 50 copies/mL. Viral blips between 50-400 copies will be allowed as long as there are not consecutive measurements \> 200 copies/mL.
- ✓Participant is not suffering from significant wasting (e.g. body mass index \<21) thought to be related to HIV disease.
Exclusion criteria
- ✕Participant has prior progressive multifocal leukoencephalopathy (PML), cryptosporidiosis of \> 1 month, or primary central nervous system (CNS) lymphoma.
- ✕Participant is pregnant or breastfeeding.
- ✕Past or current medical problems or findings from medical history, physical examination or laboratory testing that are not listed above, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may impact the quality or interpretation of the data obtained from the study.
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.